Literature DB >> 28717830

A review of drug-induced liver injury databases.

Guangwen Luo1, Yiting Shen1, Lizhu Yang1, Aiping Lu2, Zheng Xiang3,4.   

Abstract

Drug-induced liver injuries have been a major focus of current research in drug development, and are also one of the major reasons for the failure and withdrawal of drugs in development. Drug-induced liver injuries have been systematically recorded in many public databases, which have become valuable resources in this field. In this study, we provide an overview of these databases, including the liver injury-specific databases LiverTox, LTKB, Open TG-GATEs, LTMap and Hepatox, and the general databases, T3DB, DrugBank, DITOP, DART, CTD and HSDB. The features and limitations of these databases are summarized and discussed in detail. Apart from their powerful functions, we believe that these databases can be improved in several ways: by providing the data about the molecular targets involved in liver toxicity, by incorporating information regarding liver injuries caused by drug interactions, and by regularly updating the data.

Entities:  

Keywords:  Databases; Drug-induced liver injury; Hepatotoxicity; Liver toxicity; Review

Mesh:

Year:  2017        PMID: 28717830     DOI: 10.1007/s00204-017-2024-8

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

1.  Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft model.

Authors:  Martin Perreault; René Maltais; Jenny Roy; Sylvain Picard; Ion Popa; Nicolas Bertrand; Donald Poirier
Journal:  Invest New Drugs       Date:  2018-07-30       Impact factor: 3.850

2.  Carvedilol-Induced Liver Injury, a Rare Cause of Mixed Hepatitis: A Clinical Case.

Authors:  João Rua; Ana Rita Prata; Ricardo Marques; Rafael Silva; Bráulio Gomes; João Fraga; Jorge Fortuna
Journal:  GE Port J Gastroenterol       Date:  2018-07-10

Review 3.  Developments in toxicogenomics: understanding and predicting compound-induced toxicity from gene expression data.

Authors:  Benjamin Alexander-Dann; Lavinia Lorena Pruteanu; Erin Oerton; Nitin Sharma; Ioana Berindan-Neagoe; Dezső Módos; Andreas Bender
Journal:  Mol Omics       Date:  2018-08-06

4.  Preliminary Study on Hepatoprotective Effect and Mechanism of (-)-Epigallocatechin-3-gallate against Acetaminophen-induced Liver Injury in Rats.

Authors:  Yongxu Lin; Juan Huang; Tingfang Gao; Yuanzi Wu; Da Huang; Fen Yan; Zuquan Weng
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

5.  The development and application of in silico models for drug induced liver injury.

Authors:  Xiao Li; Yaojie Chen; Xinrui Song; Yuan Zhang; Huanhuan Li; Yong Zhao
Journal:  RSC Adv       Date:  2018-02-20       Impact factor: 4.036

6.  Real-World Evidence for COVID-19 Delta Variant's Effects on the Digestive System and Protection of Inactivated Vaccines from a Medical Center in Yangzhou, China: A Retrospective Observational Study.

Authors:  Wenjing Zhao; Yong Li; Ruijin Xie; Yuying Dong; Yan Wei; Ce Cheng; Scott Lowe; Chenyu Sun; Cunjin Wang; Ju Gao
Journal:  Int J Clin Pract       Date:  2022-08-19       Impact factor: 3.149

7.  A Pipeline for High-Throughput Concentration Response Modeling of Gene Expression for Toxicogenomics.

Authors:  John S House; Fabian A Grimm; Dereje D Jima; Yi-Hui Zhou; Ivan Rusyn; Fred A Wright
Journal:  Front Genet       Date:  2017-11-01       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.